UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.674

Sortiert nach

Dosing Guidance for Intravenous Colistin in Critically Ill Patients

Clinical infectious diseases, 2017-03, Vol.64 (5), p.565-571

2017

Link zum Volltext

Verfügbarkeit prüfen

Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?

Clinical infectious diseases, 2014-07, Vol.59 (1), p.88-94

2014

Link zum Volltext

Verfügbarkeit prüfen

Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis

FEMS microbiology reviews, 2022-01, Vol.46 (1), p.1

2022

Link zum Volltext

Verfügbarkeit prüfen

Colistin, mechanisms and prevalence of resistance

Current medical research and opinion, 2015-04, Vol.31 (4), p.707-721

2015

Link zum Volltext

Verfügbarkeit prüfen

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

The Lancet infectious diseases, 2015-02, Vol.15 (2), p.225-234

2015

Link zum Volltext

Verfügbarkeit prüfen

Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)

Emerging microbes & infections, 2020-01, Vol.9 (1), p.868-885

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Clinical infectious diseases, 2019-08, Vol.69 (5), p.769-776

2019

Link zum Volltext

Verfügbarkeit prüfen

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

Clinical infectious diseases, 2015-05, Vol.60 (9), p.1295-1303

2015

Link zum Volltext

Verfügbarkeit prüfen

Transferable resistance to colistin: a new but old threat

Journal of antimicrobial chemotherapy, 2016-08, Vol.71 (8), p.2066-2070

2016

Link zum Volltext

Verfügbarkeit prüfen

Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing

Pharmacotherapy, 2010-12, Vol.30 (12), p.1279-1291

2010

Link zum Volltext

Verfügbarkeit prüfen

Polymyxins for CNS infections: Pharmacology and neurotoxicity

Pharmacology & therapeutics (Oxford), 2018-01, Vol.181, p.85-90

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report

Critical care (London, England), 2017-06, Vol.21 (1), p.129-3, Article 129

2017

Link zum Volltext

Verfügbarkeit prüfen

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality

Clinical infectious diseases, 2017-03, Vol.64 (6), p.711-718

2017

Link zum Volltext

Verfügbarkeit prüfen

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

The Lancet infectious diseases, 2016-02, Vol.16 (2), p.161-168

2016

Link zum Volltext

Verfügbarkeit prüfen

Colistin use and colistin resistance in bacteria from animals

International journal of antimicrobial agents, 2016-12, Vol.48 (6), p.598-606

2016

Link zum Volltext

Verfügbarkeit prüfen

Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

Antimicrobial agents and chemotherapy, 2022-05, Vol.66 (5), p.e0214221

2022

Link zum Volltext

Verfügbarkeit prüfen

Colistin resistance gene mcr-1 in extended-spectrum β-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany

The Lancet infectious diseases, 2016-03, Vol.16 (3), p.282-283

2016

Link zum Volltext

Verfügbarkeit prüfen

Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms

Nature communications, 2017-12, Vol.8 (1), p.2054-12, Article 2054

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis

Journal of antimicrobial chemotherapy, 2018-01, Vol.73 (1), p.22-32

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7331-7339

2014

Link zum Volltext

Verfügbarkeit prüfen

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

Clinical microbiology and infection, 2013-01, Vol.19 (1), p.E23-E30

2013

Link zum Volltext

Verfügbarkeit prüfen

Early emergence of mcr-1 in Escherichia coli from food-producing animals

The Lancet infectious diseases, 2016-03, Vol.16 (3), p.293-293

2016

Link zum Volltext

Verfügbarkeit prüfen

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

Journal of antimicrobial chemotherapy, 2012-07, Vol.67 (7), p.1607-1615

2012

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis

Cochrane database of systematic reviews, 2017-04, Vol.4 (4), p.CD004197-CD004197

2017

Link zum Volltext

Verfügbarkeit prüfen

Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial

Critical care (London, England), 2019-11, Vol.23 (1), p.383-383, Article 383

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.674

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.404)
Mit Volltextzugriff
(1.193)

Publikationsform

Artikel
(1.674)

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.470)
Science & Technology
(1.243)
Life Sciences & Biomedicine
(1.191)
Colistin - Therapeutic Use
(1.185)
Anti-Bacterial Agents - Therapeutic Use
(1.147)
Colistin
(694)
Male
(649)
Female
(599)
Infectious Diseases
(526)
Microbiology
(489)
Microbial Sensitivity Tests
(439)
Anti-Bacterial Agents - Pharmacology
(432)
Middle Aged
(410)
Adult
(386)
Pharmacology & Pharmacy
(370)
Colistin - Pharmacology
(348)
Drug Resistance, Multiple, Bacterial
(339)
Aged
(319)
Antibiotics
(278)
Pseudomonas Infections - Drug Therapy
(275)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Dosing Guidance for Intravenous Colistin in Critically Ill Patients

Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?

Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis

Colistin, mechanisms and prevalence of resistance

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

Transferable resistance to colistin: a new but old threat

Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing

Polymyxins for CNS infections: Pharmacology and neurotoxicity

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report

Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

Colistin use and colistin resistance in bacteria from animals

Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

Colistin resistance gene mcr-1 in extended-spectrum β-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany

Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms

Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis

Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

Early emergence of mcr-1 in Escherichia coli from food-producing animals

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis

Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial

Suchergebnisse filtern